Association of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers with risk of mortality, severity or SARS-CoV-2 test positivity in COVID-19 patients: meta-analysis

The effects of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) in the treatment of COVID-19 are highly debated. This study was aimed to assess aggregated risk by investigating the association of ACEIs/ARBs users against non-users of ACEIs/ARBs with the ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Biswas, Mohitosh, Kali, Most. Sumaiya Khatun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930241/
https://www.ncbi.nlm.nih.gov/pubmed/33658619
http://dx.doi.org/10.1038/s41598-021-84678-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930241/
https://www.ncbi.nlm.nih.gov/pubmed/33658619
http://dx.doi.org/10.1038/s41598-021-84678-9

Ejemplares similares